The European Union has approved GSK's drug Blenrep to treat relapsed or treatment-resistant forms of a cancer affecting blood plasma cells, the British drugmaker said on Thursday.

Platelet-rich plasma (PRP) is a fraction of blood plasma; its concentration of platelets is of great value in regenerative ...

Researchers in the Microfluidics Cluster on the Alava campus design a portable, cost-effective system for generating ...

Platelet-rich plasma (PRP) is a fraction of blood plasma; its concentration of platelets is of great value in regenerative ...

Table of Contents The Real Caloric Story Behind Plasma Donation Your Body’s Protein Manufacturing Marathon The Stress ...

In 2021, approximately 537 million people were diagnosed with diabetes mellitus. With rates expected to rise, health expenditures are projected to reach one trillion USD by 2030. Thus, measuring ...